The COVID-19 epidemic in recent years has been produced by various coronavirus strains that nearly destroyed world health policies and economics. Emerging viral strains exacerbated the pandemic. Huge investments have been made in preventative vaccines to combat the disease, but the genetic instability of these viruses has hampered their usefulness. However, in addition to traditional therapeutic approaches, nutraceuticals have been considered efficacious in preventing and or treating COVID-19 and post-COVID syndrome. In this context, nutraceuticals such as vitamins or dietary supplements including multiple vitamins and minerals and propolis have been widely studied for their significant impact on viral respiratory diseases like SARS-CoV-2 and COVID-19. Some of these nutraceuticals having antioxidant, antiinflammatory, and immune-modulatory properties have been highly recommended for use as an adjunct option to moderate the adverse effects associated with the COVID-19 pandemic. In this review, we intend to present the recent understanding and converse scientific implications for the use of nutraceutical antioxidants such as vitamins, minerals, probiotics, and polyphenols like bee propolis, in the management of viral respiratory diseases and post-COVID-19 syndrome. Future challenges and limitations regarding the use and bioavailability of these ingredients, and dose-response studies are further emphasized.
{"title":"Antioxidant Nutraceuticals: Their Adjunct Role in the Management of COVID-19 Infections and Post-COVID Syndrome.","authors":"Naheed Mojgani, Maryam Dadar, Youcef Shahali, Jesus Simal-Gandara, Prashant Kumar, Sumel Ashique, Mithun Bhowmick, Himanshu Kumar","doi":"10.2174/0118715265320091241017161919","DOIUrl":"10.2174/0118715265320091241017161919","url":null,"abstract":"<p><p>The COVID-19 epidemic in recent years has been produced by various coronavirus strains that nearly destroyed world health policies and economics. Emerging viral strains exacerbated the pandemic. Huge investments have been made in preventative vaccines to combat the disease, but the genetic instability of these viruses has hampered their usefulness. However, in addition to traditional therapeutic approaches, nutraceuticals have been considered efficacious in preventing and or treating COVID-19 and post-COVID syndrome. In this context, nutraceuticals such as vitamins or dietary supplements including multiple vitamins and minerals and propolis have been widely studied for their significant impact on viral respiratory diseases like SARS-CoV-2 and COVID-19. Some of these nutraceuticals having antioxidant, antiinflammatory, and immune-modulatory properties have been highly recommended for use as an adjunct option to moderate the adverse effects associated with the COVID-19 pandemic. In this review, we intend to present the recent understanding and converse scientific implications for the use of nutraceutical antioxidants such as vitamins, minerals, probiotics, and polyphenols like bee propolis, in the management of viral respiratory diseases and post-COVID-19 syndrome. Future challenges and limitations regarding the use and bioavailability of these ingredients, and dose-response studies are further emphasized.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265320091"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Background: </strong>Streptococcal Toxic Shock Syndrome (STSS) is a life-threatening condition caused by bacterial toxins. The STSS triad encompasses high fever, hypotensive shock, and a "sunburn-like" rash with desquamation. STSS, like Toxic Shock Syndrome (TSS), is a rare complication of streptococcal infections caused by Group A <i>Streptococcus</i> (GAS), <i>Streptococcal pyogenes (S. pyogenes). Staphylococcus aureus</i> is the most frequently isolated bacterial species associated with TSS. Risk factors for STSS include older age, skin wounds, recent viral infection with open sores, recent surgery, nasal packing, use of tampons or other devices, such as menstrual cups/contraceptive sponges/diaphragms, or any other chronic illness, like diabetes or alcohol/drug abuse. Our case presents a patient who did not have any of these risk factors.</p><p><strong>Case presentation: </strong>A 25-year-old male was admitted to the Intensive Care Unit (ICU) after requiring intubation with mechanical ventilation and pressor support in the setting of septic shock. Septic arthritis was suspected, and blood and bone cultures were positive for <i>S. pyogenes</i>. Arthrocentesis of the affected knee (with fluid analysis and cytology) was positive for <i>Streptococcal pyogenes</i>. Infectious disease was consulted and the patient was empirically started on antibiotics. Kidney function continued to worsen, requiring hemodialysis. He no longer demonstrated brainstem reflexes, which prompted neurology consultation to rule out central nervous system dissemination. Superantigens are pyrogenic exotoxins secreted by different strains of <i>S. pyogenes</i> and are responsible for the many symptoms of STSS that patients present with. Throat infections by the bacteria, leading to streptococcal pharyngitis, are mediated by toxin release and known to cause scarlet fever and, very rarely, STSS. The postinfectious non-pyogenic, non-suppurative syndromes of GAS are autoimmune in nature, which include rheumatic fever, acute glomerulonephritis, and very rarely, reactive arthritis. This cross-reactivity of antibodies with body tissue via a mechanism of molecular mimicry can follow streptococcal infections, like streptococcal pharyngitis. Renal disease can also occur after a localized skin infection, also known as streptococcal impetigo. Despite the relationship of STSS with throat infections, there seem to be no reported cases of STSS secondary to septic arthritis in adult patients with no pertinent past medical history or other risk factors that could contribute to the condition.</p><p><strong>Conclusion: </strong>Streptococcal septic arthritis is an uncommon orthopedic emergency with high morbidity and mortality that requires emergent medical management. Septic arthritis needs to be treated with systemic antibiotics and joint aspiration, also known as arthrocentesis, which may be required more than once for complete recovery and avoidance of joint destruction. STSS is
{"title":"Streptococcal Toxic Shock Syndrome (STSS) Secondary to Monoarticular Septic Arthritis Leading to Multiorgan Failure in a Patient without Underlying Comorbidities: Emphasizing Early Diagnosis and Management Strategies.","authors":"Awad Chady, Chong Brandon, Samaniego Michelle, Omar Fahad, Omar Asad","doi":"10.2174/0118715265326740241218080319","DOIUrl":"10.2174/0118715265326740241218080319","url":null,"abstract":"<p><strong>Background: </strong>Streptococcal Toxic Shock Syndrome (STSS) is a life-threatening condition caused by bacterial toxins. The STSS triad encompasses high fever, hypotensive shock, and a \"sunburn-like\" rash with desquamation. STSS, like Toxic Shock Syndrome (TSS), is a rare complication of streptococcal infections caused by Group A <i>Streptococcus</i> (GAS), <i>Streptococcal pyogenes (S. pyogenes). Staphylococcus aureus</i> is the most frequently isolated bacterial species associated with TSS. Risk factors for STSS include older age, skin wounds, recent viral infection with open sores, recent surgery, nasal packing, use of tampons or other devices, such as menstrual cups/contraceptive sponges/diaphragms, or any other chronic illness, like diabetes or alcohol/drug abuse. Our case presents a patient who did not have any of these risk factors.</p><p><strong>Case presentation: </strong>A 25-year-old male was admitted to the Intensive Care Unit (ICU) after requiring intubation with mechanical ventilation and pressor support in the setting of septic shock. Septic arthritis was suspected, and blood and bone cultures were positive for <i>S. pyogenes</i>. Arthrocentesis of the affected knee (with fluid analysis and cytology) was positive for <i>Streptococcal pyogenes</i>. Infectious disease was consulted and the patient was empirically started on antibiotics. Kidney function continued to worsen, requiring hemodialysis. He no longer demonstrated brainstem reflexes, which prompted neurology consultation to rule out central nervous system dissemination. Superantigens are pyrogenic exotoxins secreted by different strains of <i>S. pyogenes</i> and are responsible for the many symptoms of STSS that patients present with. Throat infections by the bacteria, leading to streptococcal pharyngitis, are mediated by toxin release and known to cause scarlet fever and, very rarely, STSS. The postinfectious non-pyogenic, non-suppurative syndromes of GAS are autoimmune in nature, which include rheumatic fever, acute glomerulonephritis, and very rarely, reactive arthritis. This cross-reactivity of antibodies with body tissue via a mechanism of molecular mimicry can follow streptococcal infections, like streptococcal pharyngitis. Renal disease can also occur after a localized skin infection, also known as streptococcal impetigo. Despite the relationship of STSS with throat infections, there seem to be no reported cases of STSS secondary to septic arthritis in adult patients with no pertinent past medical history or other risk factors that could contribute to the condition.</p><p><strong>Conclusion: </strong>Streptococcal septic arthritis is an uncommon orthopedic emergency with high morbidity and mortality that requires emergent medical management. Septic arthritis needs to be treated with systemic antibiotics and joint aspiration, also known as arthrocentesis, which may be required more than once for complete recovery and avoidance of joint destruction. STSS is ","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265326740"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.2174/0118715265307531240801091445
Sushil Kumar Singh, Shyam Sundar Pancholi
Posaconazole is an antifungal medication used primarily to treat invasive fungal infections caused by various organisms, such as Aspergillus, Candida, and certain molds. It belongs to the class of drugs known as triazole antifungals. Clinical studies have reported posaconazole to be effective in treating various invasive fungal infections, especially in patients who are immunocompromised, such as those with weakened immune systems due to conditions like HIV/AIDS, undergoing chemotherapy, or having received an organ transplant. It has effectively treated invasive candidiasis, aspergillosis, zygomycosis, and other serious fungal infections. The effectiveness of the drug varies based on factors, such as the type of infection, the patient's immune status, and the site of infection. This review describes the types of infection, the drug's safety profile, the development of resistance to posaconazole, and strategies to manage or prevent resistance.
{"title":"Role of Posaconazole Drug in the Treatment of Invasive Fungal Disease: A Review.","authors":"Sushil Kumar Singh, Shyam Sundar Pancholi","doi":"10.2174/0118715265307531240801091445","DOIUrl":"10.2174/0118715265307531240801091445","url":null,"abstract":"<p><p>Posaconazole is an antifungal medication used primarily to treat invasive fungal infections caused by various organisms, such as Aspergillus, Candida, and certain molds. It belongs to the class of drugs known as triazole antifungals. Clinical studies have reported posaconazole to be effective in treating various invasive fungal infections, especially in patients who are immunocompromised, such as those with weakened immune systems due to conditions like HIV/AIDS, undergoing chemotherapy, or having received an organ transplant. It has effectively treated invasive candidiasis, aspergillosis, zygomycosis, and other serious fungal infections. The effectiveness of the drug varies based on factors, such as the type of infection, the patient's immune status, and the site of infection. This review describes the types of infection, the drug's safety profile, the development of resistance to posaconazole, and strategies to manage or prevent resistance.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265307531"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: SNP based association studies have revolutionized the field of biomedicines. Enteric fever is a systemic disease with etiologic agent Salmonella enterica serovar typhi and paratyphi. It is a serious health issue worldwide and presents wide variations in incidence, rates, and severity. Previous investigations revealed that genetic variations may lead to susceptibility to typhoid fever. The current study was performed to investigate the potential association of PARK2_e01(-697) polymorphism with the susceptibility to typhoid in the Punjabi population.
Methods: For this case-control study, blood samples obtained from typhoid patients with positive Typhidot or blood culture test (n=72) and healthy controls (n=73) were processed for DNA extraction. The polymorphism PARK2_e01(-697) analysis was carried out by using PCR and RFLP.
Results: No allelic association was found between PARK2_e01(-697) and susceptibility to typhoid fever in the understudy population.
Conclusion: This case control study is the demonstration of the non-association of PARK2_e01(-697) with typhoid in the Pakistani population. Future research, using larger population size, will help to elucidate the role of PARK2_e01(-697) polymorphism in typhoid pathogenesis.
背景:基于 SNP 的关联研究给生物医学领域带来了革命性的变化。肠热病是一种全身性疾病,病原体是肠炎沙门氏菌(Salmonella enterica serovar typhi and paratyphi)。它是全球范围内一个严重的健康问题,在发病率、发病率和严重程度上存在很大差异。以往的调查显示,基因变异可能导致对伤寒的易感性。本研究旨在调查 PARK2_e01(-697) 多态性与旁遮普人伤寒易感性的潜在关联:在这项病例对照研究中,对伤寒患者(72 人)和健康对照组(73 人)的血液样本进行了 DNA 提取。结果显示,PARK2_e01(-697)的等位基因与伤寒患者的血型没有关联:结果:在研究对象中未发现 PARK2_e01(-697) 与伤寒易感性之间的等位基因关联:这项病例对照研究表明,在巴基斯坦人群中,PARK2_e01(-697)与伤寒无关。未来的研究将使用更大规模的人群,这将有助于阐明 PARK2_e01(-697)多态性在伤寒发病机制中的作用。
{"title":"The <i>PARK2_e01(-697)</i> Polymorphism does not Associate with Susceptibility to Typhoid in Punjabi Population, Pakistan: A Case Control Study.","authors":"Rizwana Kousar, Ayesha Waheed, Rida Naz, Ghazala Kaukab Raja, Umm-E Kalsoom, Sadia Latif","doi":"10.2174/0118715265305304240918063848","DOIUrl":"10.2174/0118715265305304240918063848","url":null,"abstract":"<p><strong>Background: </strong>SNP based association studies have revolutionized the field of biomedicines. Enteric fever is a systemic disease with etiologic agent <i>Salmonella enterica</i> serovar typhi and <i>paratyphi</i>. It is a serious health issue worldwide and presents wide variations in incidence, rates, and severity. Previous investigations revealed that genetic variations may lead to susceptibility to typhoid fever. The current study was performed to investigate the potential association of <i>PARK2_e01(-697)</i> polymorphism with the susceptibility to typhoid in the Punjabi population.</p><p><strong>Methods: </strong>For this case-control study, blood samples obtained from typhoid patients with positive Typhidot or blood culture test (n=72) and healthy controls (n=73) were processed for DNA extraction. The polymorphism <i>PARK2_e01(-697)</i> analysis was carried out by using PCR and RFLP.</p><p><strong>Results: </strong>No allelic association was found between <i>PARK2_e01(-697)</i> and susceptibility to typhoid fever in the understudy population.</p><p><strong>Conclusion: </strong>This case control study is the demonstration of the non-association of <i>PARK2_e01(-697)</i> with typhoid in the Pakistani population. Future research, using larger population size, will help to elucidate the role of <i>PARK2_e01(-697)</i> polymorphism in typhoid pathogenesis.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265305304"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The pink eye outbreak in 2023 was caused due to humid weather conditions in most regions of India. The most affected states include Delhi, Gujrat (21% cases), Maharashtra (30%), Himachal Pradesh (4%) and Karnataka (4%). The epidemiological data indicates that males have a high prevalence rate as compared to females; urban areas were most affected, and professionals as well as students were the population group that had the highest prevalence rate. The most common clinical manifestations were the presence of red eye, eye discharge, grittiness, and eyelashes being stuck together. One of the hallmarks of histopathology is a cobblestone formation of flattened nodules with central vascular centers. Conjunctivitis is a virusmediated immune response accompanied by inflammation, which proceeds the immune reaction, giving rise to vasodilation, pseudo membrane formation, and conjunctivital discharge. The gold standard for the diagnosis of Conjunctivitis is the Adenoplus kit using PCR technology; apart from this slit lamp biomicroscope can be used for the evaluation. It is the need of the hour to spread awareness about the Pink Eye disease and the measures to prevent it.
{"title":"India's Pink-Eye Mystery: Decoding the 2023 Conjunctivitis Outbreak.","authors":"Tuhin James Paul, Ayushreeya Banga, Ashmeen Kaur, Sonakshi Garg, Amandeep Singh","doi":"10.2174/0118715265291922240625054709","DOIUrl":"10.2174/0118715265291922240625054709","url":null,"abstract":"<p><p>The pink eye outbreak in 2023 was caused due to humid weather conditions in most regions of India. The most affected states include Delhi, Gujrat (21% cases), Maharashtra (30%), Himachal Pradesh (4%) and Karnataka (4%). The epidemiological data indicates that males have a high prevalence rate as compared to females; urban areas were most affected, and professionals as well as students were the population group that had the highest prevalence rate. The most common clinical manifestations were the presence of red eye, eye discharge, grittiness, and eyelashes being stuck together. One of the hallmarks of histopathology is a cobblestone formation of flattened nodules with central vascular centers. Conjunctivitis is a virusmediated immune response accompanied by inflammation, which proceeds the immune reaction, giving rise to vasodilation, pseudo membrane formation, and conjunctivital discharge. The gold standard for the diagnosis of Conjunctivitis is the Adenoplus kit using PCR technology; apart from this slit lamp biomicroscope can be used for the evaluation. It is the need of the hour to spread awareness about the Pink Eye disease and the measures to prevent it.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e190724232040"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141750163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Confronting and Addressing the Presence of Psittacosis in Europe.","authors":"Shivang Saxena, Shubhi Saxena, Nihar Ranjan Sahoo, Amandeep Singh","doi":"10.2174/0118715265322768240807102042","DOIUrl":"10.2174/0118715265322768240807102042","url":null,"abstract":"","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265322768"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The healthcare system has been greatly affected by the COVID-19 pandemic, resulting in an increase in secondary and co-infections among patients. Factors like pulmonary damage and weakened immune systems make patients more susceptible to fungal infections. Mucormycosis, an opportunistic fungal infection, prospers in environments with limited oxygen, and elevated glucose levels due to conditions such as diabetes and steroid use, as well as in acidic environments from metabolic acidosis and diabetic ketoacidosis, where it demonstrates heightened germination ability. Recognizing these complications is critical to minimize harm to patients. The insights gained from this review can improve our understanding of how fungal infections develop in connection to COVID-19, leading to better predictive algorithms, tailored care plans, enhanced antifungal treatments, quicker diagnostics, and improved management strategies.
{"title":"Mucormycosis and COVID-19: Unraveling the Interplay of Fungal Infection in a Global Health Crisis: An Overview.","authors":"Ali Moheb-Alian, Ali Akbari, Saghi Nooraei, Howra Bahrulolum, Zoheir Mohammadian Farsani, Negin Mokhtari, Mozhdeh Sadat Ebadi, Arezoo Mohammadian Farsani, Seyedmoein Khatami, Mohammadmahdi Esmaeili, Zahra Keykhaee, Mohammad Hossein Heydargoy, Zahra Rafiei, Gholamreza Ahmadian","doi":"10.2174/0118715265310191240919060621","DOIUrl":"10.2174/0118715265310191240919060621","url":null,"abstract":"<p><p>The healthcare system has been greatly affected by the COVID-19 pandemic, resulting in an increase in secondary and co-infections among patients. Factors like pulmonary damage and weakened immune systems make patients more susceptible to fungal infections. Mucormycosis, an opportunistic fungal infection, prospers in environments with limited oxygen, and elevated glucose levels due to conditions such as diabetes and steroid use, as well as in acidic environments from metabolic acidosis and diabetic ketoacidosis, where it demonstrates heightened germination ability. Recognizing these complications is critical to minimize harm to patients. The insights gained from this review can improve our understanding of how fungal infections develop in connection to COVID-19, leading to better predictive algorithms, tailored care plans, enhanced antifungal treatments, quicker diagnostics, and improved management strategies.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265310191"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Infectious disorders known as Neglected Tropical Diseases (NTDs) initially affect the world's underprivileged citizens. They have been disregarded for many years, first as a result of a general indifference to such a developing world and, more recently, as an outcome of the intense attention on AIDS, TB, and malaria. Tropical diseases mostly affect the region where health and hygiene are sacrificed, and most of the population lacks access to sufficient food and living resources. WHO has drafted and released the directions for regulation, prevention, and successful eradication of NTDs as per the revised roadmap of 2021-2030. This shifts from vertical disease programs to integrated cross-cutting methods. In the current work, we have provided comprehensive information on various aspects of neglected tropical diseases, including the clinical management of NTDs. This encompasses the causative agent of the diseases, their symptoms, pathogenesis, diagnosis, treatment, prognosis, and epidemiological perspective of major NTDs. This review will shed light on several perspectives of NTDs having influential roles in proposing strategies to control and treat them around the world.
{"title":"A Review on the Epidemiology and Clinical Management of Neglected Tropical Diseases.","authors":"Medha Dwivedi, Aiswarya Pawar, Mahima Kori, Hitendra Yadav, Manish Dwivedi","doi":"10.2174/0118715265305007240718081727","DOIUrl":"10.2174/0118715265305007240718081727","url":null,"abstract":"<p><p>Infectious disorders known as Neglected Tropical Diseases (NTDs) initially affect the world's underprivileged citizens. They have been disregarded for many years, first as a result of a general indifference to such a developing world and, more recently, as an outcome of the intense attention on AIDS, TB, and malaria. Tropical diseases mostly affect the region where health and hygiene are sacrificed, and most of the population lacks access to sufficient food and living resources. WHO has drafted and released the directions for regulation, prevention, and successful eradication of NTDs as per the revised roadmap of 2021-2030. This shifts from vertical disease programs to integrated cross-cutting methods. In the current work, we have provided comprehensive information on various aspects of neglected tropical diseases, including the clinical management of NTDs. This encompasses the causative agent of the diseases, their symptoms, pathogenesis, diagnosis, treatment, prognosis, and epidemiological perspective of major NTDs. This review will shed light on several perspectives of NTDs having influential roles in proposing strategies to control and treat them around the world.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":"e18715265305007"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}